HK2 and ovarian carcinoma: To investigate whether HK2 is involved in the development and progression of human ovarian carcinoma, immunohistochemistry (IHC) was used to detect HK2 expression in the normal human ovarian (NO), well differentiated epithelial ovarian cancer (WDEOC) and poorly differentiated epithelial ovarian cancer (PDEOC).